• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza A virus infection predisposes hosts to secondary infection with different Streptococcus pneumoniae serotypes with similar outcome but seroty

tetano

Editor, Senior Moderator
Infect Immun. 2016 Sep 19. pii: IAI.00422-16. [Epub ahead of print]
[h=1]Influenza A virus infection predisposes hosts to secondary infection with different Streptococcus pneumoniae serotypes with similar outcome but serotype-specific manifestation.[/h] Sharma-Chawla N[SUP]1[/SUP], Sender V[SUP]2[/SUP], Kershaw O[SUP]3[/SUP], Gruber AD[SUP]3[/SUP], Volckmar J[SUP]4[/SUP], Henriques-Normark B[SUP]5[/SUP], Stegemann-Koniszewski S[SUP]6[/SUP], Bruder D[SUP]6[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza A virus (IAV) and Streptococcus pneumoniae (S. pn.) are major causes of respiratory tract infections, particularly during co-infection. The synergism between these two pathogens is characterized by a complex network of dysregulated immune responses, some of which last until recovery post IAV infection. Despite the high serotype-diversity of S. pn. and the serotype-replacement observed since the introduction of conjugate vaccines, little is known about pneumococcal strain-dependency in the enhanced susceptibility to severe secondary S. pn. infection following IAV infection. Thus we studied how pre-infection with IAV alters host susceptibility to different S. pn. strains with varying degrees of invasiveness using a highly invasive serotype 4, an invasive serotype 7F and a carrier serotype 19F strain. A murine model of pneumococcal co-infection during the acute phase of IAV infection showed a significantly increased degree of pneumonia and mortality for all tested pneumococcal strains at otherwise sublethal doses. The incidence and kinetics of systemic dissemination however remained bacterial strain-dependent. Furthermore we observed strain-specific alterations in the pulmonary levels of alveolar macrophages, neutrophils and inflammatory mediators ultimately affecting immunopathology. During the recovery phase following IAV infection, bacterial growth in the lungs and systemic dissemination were enhanced in a strain-dependent manner. Altogether, this study shows that acute IAV infection predisposes the host to lethal S. pn. infection irrespective of the pneumococcal serotype, while the long lasting synergism between IAV and S. pn. is bacterial strain-dependent. These results hold implications for developing tailored therapeutic treatment regimens for dual infections during future IAV outbreaks.
Copyright ? 2016, American Society for Microbiology. All Rights Reserved.


PMID: 27647871 DOI: 10.1128/IAI.00422-16
[PubMed - as supplied by publisher]
 
Back
Top Bottom